Tony T. Kalajian, SVP-Chief Accounting Officer at OncoCyte Corp (OCX), bought 10,000 shares at $1.98 ($20K) on 2019-09-13, disclosed to the SEC on 2019-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.